FDA Inspection 1301880 — Genzyme Ireland Limited
The FDA completed an inspection of Genzyme Ireland Limited on Jan 20, 2026 in Waterford. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Biologics.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- Jan 20, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Waterford (Ireland)